Kidney Damage in Patients With Normal eGFR

Summary

This is a pilot study, randomized, double-blind, parallel group comparison of two iodinated contrast agents used during percutaneous coronary intervention (PCI). All patients enrolled must have normal eGFR. Statistical summaries will be presented to analyse the various laboratory tests for the two groups.

Timeline

Start

2010-12

Primary completion

2012-04

Completion

2012-04

Drugs

Indications